NASDAQ · XTLB
XTL Biopharmaceuticals Ltd.
Healthcare · Biotechnology
$2.52
Down-$0.12 (-4.76%)
Updated Sep 11, 2026, 1:13 PM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.63M
- P/E ratio
- -4.03
- Dividend yield
- 0.00%
- 52-week range
- $2.01 – $10.28
- Volume
- 6.26K
- Avg. volume
- 813.17K
Price performance
XTLB price history
1M range · 19 trading sessions · Daily adjusted prices
XTLB closed at $2.52 after 19 trading sessions, down 10.00% for the selected period.
- Last close
- $2.52
- Period change
- -10.00%
- Period low
- $2.32
- Period high
- $3.23
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 9, 2026 | $2.436 | $2.5602 | $2.40 | $2.52 | 6.26K |
| Sep 8, 2026 | $2.5297 | $2.53 | $2.5297 | $2.53 | 666.55 |
| Sep 4, 2026 | $2.4322 | $2.53 | $2.4322 | $2.53 | 1.83K |
| Sep 3, 2026 | $2.60 | $2.60 | $2.46 | $2.50 | 2.71K |
| Sep 2, 2026 | $2.35 | $2.69 | $2.32 | $2.66 | 33.32K |
| Sep 1, 2026 | $2.44 | $2.47 | $2.32 | $2.32 | 4.02K |
| Aug 31, 2026 | $2.51 | $2.575 | $2.48 | $2.49 | 7.63K |
| Aug 28, 2026 | $2.51 | $2.70 | $2.47 | $2.47 | 8.24K |
| Aug 27, 2026 | $2.4678 | $2.58 | $2.4678 | $2.58 | 2.66K |
| Aug 26, 2026 | $2.63 | $2.63 | $2.3496 | $2.58 | 2.6K |
| Aug 25, 2026 | $2.64 | $2.64 | $2.58 | $2.60 | 4.08K |
| Aug 24, 2026 | $2.66 | $2.66 | $2.6252 | $2.6252 | 1.16K |
| Aug 21, 2026 | $2.78 | $2.78 | $2.78 | $2.78 | 520.05 |
| Aug 20, 2026 | $2.83 | $3.05 | $2.7619 | $2.7619 | 4.42K |
| Aug 19, 2026 | $2.98 | $3.01 | $2.70 | $2.98 | 40.71K |
| Aug 18, 2026 | $2.55 | $3.52 | $2.55 | $3.23 | 88.09K |
| Aug 17, 2026 | $2.56 | $2.74 | $2.56 | $2.60 | 6.13K |
| Aug 14, 2026 | $2.60 | $2.96 | $2.55 | $2.785 | 3.86K |
| Aug 13, 2026 | $2.76 | $2.80 | $2.72 | $2.80 | 3.95K |
Latest XTLB news
The latest Smart Investors Daily articles mentioning XTLB.
Stock researchCompany · Financials
Loading stock research…
